OCON Therapeutics vs Ro5
OCON Therapeutics
We revolutionize women's quality of life and freedom of choice with healthier, safer uterine drug-delivery solutions
30 employees · est. 2020 · Israel
Ro5
Bioactivity. De Novo Drug Discovery. ADMET. Knowledge Graph
12 employees · est. 2018 · London, United Kingdom
Ro5 is the older company (2020 vs 2018).
Side-by-Side Comparison
| Metric | OCON Therapeutics | Ro5 |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2018 older |
| Headquarters | ||
| Headquarters | Israel | London, United Kingdom |
| Employees | ||
| Employees | 30 | 12 |
| Industry | ||
| Industry | Health Care, Pharmaceutical | AI, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series A | Seed |
| Total Funding | ||
| Total Funding | $29.50M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 7 | 3 |
| Services | ||
| Services | Development of intrauterine devices, Advanced drug delivery technologies, Non-hormonal contraceptive solutions, Treatment for abnormal uterine bleeding, Innovative therapeutic delivery for endometriosis and myomas | Development of innovative medicines targeting core aging mechanisms, Clinical-stage drug trials, AI-enabled R&D for drug discovery and development, Adaptive clinical trial design |
| Target Customers | ||
| Target Customers | Women seeking contraceptive solutions, Women experiencing heavy menstrual bleeding, Healthcare providers in women’s health, Institutions focused on innovation in femtech | Investors seeking high returns in biopharma, Healthcare providers focusing on longevity and preventive care, Institutions looking for innovative aging treatments, Pharmaceutical companies interested in strategic collaborations |
| Taxonomy | ||
| Taxonomy | Women's HealthInnovative ContraceptionNon-hormonal ContraceptionIntrauterine Drug DeliveryUterine Health SolutionsIUB™ Technology +9 | AI In Drug DiscoveryDe Novo Drug DiscoveryADMET AnalysisKnowledge GraphsDigital Transformation In PharmaR&D Software Solutions +9 |
| Website | ||
| Website | oconmed.com | Ro5.ai |
About OCON Therapeutics
OCON Therapeutics is spearheading advancements in women's healthcare with its innovative, non-invasive intra-uterine drug delivery solutions. Founded in 2020, the company operates out of Israel and focuses on enhancing the quality of life and reproductive autonomy for women worldwide. Central to it...
About Ro5
Ro5, founded in 2018 and headquartered in the United Kingdom, is making significant strides in the intersection of AI, Biotechnology, and Pharmaceutical industries. With its compelling slogan, "Bioactivity. De Novo Drug Discovery. ADMET. Knowledge Graph.", Ro5 positions itself as a pioneering force...
Also comparing in this category
Comparing more than these two?
Get OCON Therapeutics, Ro5 and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does OCON Therapeutics compare?
A PDF of OCON Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare OCON Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at OCON Therapeutics on 5 Mar 2026, and Ro5 on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.